Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Stock Forecast: Bullish Signals Pointing To $25 In 2024
In today’s recent session, 0.52 million shares of the Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) have been traded, and its beta is 1.93. Most recently the company’s